Adicet Bio Analyst Price Targets - Benzinga

Adicet Bio Inc

ACETNASDAQ

Trade with Public

Trade with Public

$9.36

0.11.08%

最終更新: Sep 3, 12:42 PM

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Adicet Bio Analyst Price Targets

Wall Street analyst price targets and consensus rating for Adicet Bio (ACET).

Price Target Range — 11 Quarters

Analyst Consensus — 9 Analysts

7Buy

2Hold

Consensus RatingBuy# Analysts9Avg. Consensus PT$25Upside to Avg. PT+163.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 6, 2026	Guggenheim	Yatin Suneja	PT Cut	Buy	$100→$90
May 5, 2026	Jefferies	Anthea Li	Assumes	Buy	$8→$19
Mar 23, 2026	HC Wainwright & Co.	Robert Burns	PT Cut	Buy	$50→$27
Mar 13, 2026	Guggenheim	Yatin Suneja	PT Cut	Buy	$128→$100
Jan 21, 2026	HC Wainwright & Co.	Robert Burns	PT Raise	Buy	$9→$50
Jan 6, 2026	Canaccord Genuity	John Newman	Maintained	Buy	$128→$18
Nov 7, 2025	HC Wainwright & Co.	Robert Burns	PT Raise	Buy	$4→$9
Oct 8, 2025	Guggenheim	Yatin Suneja	PT Raise	Buy	$7→$8
Sep 19, 2025	Guggenheim	Yatin Suneja	Maintained	Buy	$7
Jul 23, 2025	HC Wainwright & Co.	Robert Burns	Assumes	Buy	$4
Mar 21, 2025	Guggenheim	Yatin Suneja	Maintained	Buy	$7
Mar 7, 2025	Citizens Capital Markets	Reni Benjamin	Maintained	Market Perform	—
Mar 7, 2025	HC Wainwright & Co.	Edward White	Maintained	Neutral	—
Feb 27, 2025	HC Wainwright & Co.	Edward White	Maintained	Neutral	—
Feb 6, 2025	JMP Securities	Reni Benjamin	Maintained	Market Perform	—
Feb 5, 2025	HC Wainwright & Co.	Edward White	Maintained	Neutral	—
Dec 19, 2024	HC Wainwright & Co.	Edward White	Maintained	Neutral	—
Nov 18, 2024	HC Wainwright & Co.	Edward White	Maintained	Neutral	—
Oct 16, 2024	HC Wainwright & Co.	Edward White	Maintained	Neutral	—
Sep 30, 2024	Guggenheim	Michael Schmidt	Upgrade	Neutral→Buy	$7

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Guggenheim Maintains Buy on Adicet Bio, Lowers Price Target to $90

Guggenheim analyst Yatin Suneja maintains Adicet Bio (NASDAQ:ACET) with a Buy and lowers the price target from $100 to $90.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Adicet Bio, Lowers Price Target to $27

HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and lowers the price target from $50 to $27.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Adicet Bio, Lowers Price Target to $100

Guggenheim analyst Yatin Suneja maintains Adicet Bio (NASDAQ:ACET) with a Buy and lowers the price target from $128 to $100.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Adicet Bio, Raises Price Target to $50

HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and raises the price target from $9 to $50.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Adicet Bio, Raises Price Target to $9

HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and raises the price target from $4 to $9.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Adicet Bio, Raises Price Target to $8

Guggenheim analyst Yatin Suneja maintains Adicet Bio (NASDAQ:ACET) with a Buy and raises the price target from $7 to $8.

Benzinga Newsdesk